{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:52:06Z","timestamp":1793710326675,"version":"4.6.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P027661\/1"],"award-info":[{"award-number":["MR\/P027661\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P027881\/1"],"award-info":[{"award-number":["MR\/P027881\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1038\/s41433-021-01710-y","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T14:08:09Z","timestamp":1627913289000},"page":"1669-1674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Survival analysis following enucleation for uveal melanoma"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4082-2522","authenticated-orcid":false,"given":"Guy S.","family":"Negretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarega","family":"Gurudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6862-6227","authenticated-orcid":false,"given":"Beatrice","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1878-7131","authenticated-orcid":false,"given":"Bertil","family":"Damato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep S.","family":"Sagoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"key":"1710_CR1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1136\/bjophthalmol-2012-301812","volume":"96","author":"TDL Keenan","year":"2012","unstructured":"Keenan TDL, Yeates D, Goldacre MJ. Uveal melanoma in england: trends over time and geographical variation. Br J Ophthalmol. 2012;96:1415\u20139.","journal-title":"Br J Ophthalmol"},{"key":"1710_CR2","first-page":"1","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager MJ, Shields CL, Cebulla CM, Abdel-Rahman MH, Grossniklaus HE, Stern MH, et al. Uveal melanoma. Nat Rev. 2020;6:1\u201325.","journal-title":"Nat Rev"},{"key":"1710_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1167\/iovs.61.4.35","volume":"61","author":"B Damato","year":"2020","unstructured":"Damato B, Eleuteri A, Hussain R, Kalirai H, Thornton S, Taktak A, et al. Parsimonious models for predicting mortality from choroidal melanoma. Invest Ophthalmol Vis Sci. 2020;61:35. 9","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1710_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10897-009-9223-2","volume":"18","author":"TM Beran","year":"2009","unstructured":"Beran TM, McCannel TA, Stanton AL, Straatsma BR, Burgess BL. Reactions to and desire for prognostic testing in choroidal melanoma patients. J Genet Couns. 2009;18:265\u201374.","journal-title":"J Genet Couns"},{"key":"1710_CR5","first-page":"813","volume-title":"AJCC Cancer Staging Manual","year":"2017","unstructured":"Amin MB, Edge S, Greene F, et al. eds. AJCC Cancer Staging Manual. 8th ed. Cham, Switzerland: Springer; 2017. p. 813\u201326.","edition":"8th ed."},{"key":"1710_CR6","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.2012.45.2771","volume":"31","author":"E Kujala","year":"2013","unstructured":"Kujala E, Damato B, Coupland SE, Desjardins L, Bechrakis NE, Grange JD, et al. Staging of ciliary body and choroidal melanomas based on anatomic extent. J Clin Oncol. 2013;31:2825\u201331.","journal-title":"J Clin Oncol"},{"key":"1710_CR7","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1167\/iovs.16-20212","volume":"58","author":"M Dogrus\u00f6z","year":"2017","unstructured":"Dogrus\u00f6z M, Bagger M, van Duinen SG, Kroes WG, Ruivenkamp CA, B\u00f6hringer S, et al. The prognostic value of AJCC staging in uveal melanoma is enhanced by adding chromosome 3 and 8q status. Invest Ophthalmol Vis Sci. 2017;58:833\u201342.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1710_CR8","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.ophtha.2007.06.012","volume":"114","author":"B Damato","year":"2007","unstructured":"Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology. 2007;114:1925\u201331.","journal-title":"Ophthalmology"},{"key":"1710_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1167\/iovs.14-15571","volume":"56","author":"M Bagger","year":"2014","unstructured":"Bagger M, Andersen MT, Andersen KK, Heegaard S, Andersen MK, Kiilgaard JF. The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci. 2014;56:438\u201344.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1710_CR10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1001\/jamaophthalmol.2016.0913","volume":"134","author":"SD Walter","year":"2016","unstructured":"Walter SD, Chao DL, Feuer W, Schiffman J, Char DH, Harbour JW. Prognostic implications of tumor diameter in association with gene expression profile for uveal melanoma. JAMA Ophthalmol. 2016;134:734\u201340.","journal-title":"JAMA Ophthalmol"},{"key":"1710_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/cancers12020477","volume":"12","author":"A Cunha Rola","year":"2020","unstructured":"Cunha Rola A, Taktak A, Eleuteri A, Kalirai H, Heimann H, Hussain R, et al. Multicenter external validation of the liverpool uveal melanoma prognosticator online: an OOG collaborative study. Cancers (Basel). 2020;12:477.","journal-title":"Cancers (Basel)"},{"key":"1710_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1590\/S0004-27492013000200004","volume":"76","author":"JJ Augsburger","year":"2013","unstructured":"Augsburger JJ, Corr\u00eaa ZM, Trichopoulos N. Prognostic implications of cytopathologic classification of melanocytic uveal tumors evaluated by fine-needle aspiration biopsy. Arq Bras Oftalmol. 2013;76:72\u20139.","journal-title":"Arq Bras Oftalmol"},{"key":"1710_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"1710_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/biostatistics\/kxy006","volume":"20","author":"P Blanche","year":"2019","unstructured":"Blanche P, Kattan MW, Gerds TA. The c-index is not proper for the evaluation of $t$-year predicted risks. Biostatistics. 2019;20:347\u201357.","journal-title":"Biostatistics"},{"key":"1710_CR15","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1167\/iovs.11-8697","volume":"53","author":"T van den Bosch","year":"2012","unstructured":"van den Bosch T, van Beek JG, Vaarwater J, Verdijk RM, Naus NC, Paridaens D, et al. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. Invest Ophthalmol Vis Sci. 2012;53:2668\u201374.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1710_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/tvst.8.2.18","volume":"8","author":"AR Afshar","year":"2019","unstructured":"Afshar AR, Damato BE, Stewart JM, Zablotska LB, Roy R, Olshen AB, et al. Next-generation sequencing of uveal melanoma for detection of genetic alterations predicting metastasis. Transl Vis Sci Technol. 2019;8:18.","journal-title":"Transl Vis Sci Technol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01710-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01710-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01710-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T07:10:45Z","timestamp":1658473845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01710-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1710"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01710-y","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]},"assertion":[{"value":"8 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}